Aptevo Therapeutics Inc.
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 2.65% | 123.82% | 339.93% | -75.45% | 12.40% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 37.06% | -4.91% | 17.88% | 45.73% | -43.43% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 1,007.79% | -6.10% | -31.67% | -88.24% | 63.46% |
| Total Current Assets | 1.91% | 104.39% | 207.21% | -66.16% | 6.46% |
|
|
|||||
| Total Current Assets | 1.91% | 104.39% | 207.21% | -66.16% | 6.46% |
| Net Property, Plant & Equipment | -5.38% | -4.31% | -4.05% | -3.99% | -3.93% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 0.73% | 72.79% | 87.29% | -46.49% | 2.94% |
|
|
|||||
| Total Accounts Payable | -60.48% | -23.56% | -23.38% | 205.07% | -64.84% |
| Total Accrued Expenses | 126.56% | 82.79% | 120.34% | -88.75% | 355.21% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 8.25% | 0.00% | -- | -- | 9.71% |
| Total Finance Division Other Current Liabilities | -- | 368.92% | -86.93% | -- | -- |
| Total Other Current Liabilities | -- | 368.92% | -86.93% | -- | -- |
| Total Current Liabilities | 7.77% | 14.78% | -9.31% | -13.11% | 5.53% |
|
|
|||||
| Total Current Liabilities | 7.77% | 14.78% | -9.31% | -13.11% | 5.53% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -5.69% | -5.20% | -4.82% | -4.47% | -4.16% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 2.18% | 5.54% | -7.28% | -9.42% | 1.03% |
|
|
|||||
| Common Stock & APIC | 2.05% | 7.46% | 5.62% | 0.07% | 2.71% |
| Retained Earnings | -2.19% | -3.47% | -2.44% | -2.59% | -2.62% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -0.06% | 166.58% | 542.91% | -130.98% | 7.58% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -0.06% | 166.58% | 542.91% | -130.98% | 7.58% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -0.06% | 166.58% | 542.91% | -130.98% | 7.58% |
|
|
|||||